142 related articles for article (PubMed ID: 27677162)
1. Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults.
Jenabian MA; Costiniuk CT; Mehraj V; Ghazawi FM; Fromentin R; Brousseau J; Brassard P; Bélanger M; Ancuta P; Bendayan R; Chomont N; Routy JP;
AIDS; 2016 Nov; 30(18):2777-2786. PubMed ID: 27677162
[TBL] [Abstract][Full Text] [Related]
2. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy.
Chen J; Xun J; Yang J; Ji Y; Liu L; Qi T; Wang Z; Zhang R; Shen Y; Ponte R; Mehraj V; Routy JP; Lu H
Clin Infect Dis; 2019 Apr; 68(8):1274-1281. PubMed ID: 30107503
[TBL] [Abstract][Full Text] [Related]
3. HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy.
Costiniuk CT; Salahuddin S; Farnos O; Olivenstein R; Pagliuzza A; Orlova M; Schurr E; De Castro C; Bourbeau J; Routy JP; Ancuta P; Chomont N; Jenabian MA
AIDS; 2018 Oct; 32(16):2279-2289. PubMed ID: 30102653
[TBL] [Abstract][Full Text] [Related]
4. Drug efflux transporters and metabolic enzymes in human circulating and testicular T-cell subsets: relevance to HIV pharmacotherapy.
Whyte-Allman SK; Hoque MT; Gilmore JC; Kaul R; Routy JP; Bendayan R;
AIDS; 2020 Aug; 34(10):1439-1449. PubMed ID: 32310902
[TBL] [Abstract][Full Text] [Related]
5. Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy.
Bachtel ND; Beckerle GA; Mota TM; Rougvie MM; Raposo RAS; Jones RB; Nixon DF; Apps R
AIDS Res Hum Retroviruses; 2019 Jan; 35(1):108-111. PubMed ID: 30198299
[TBL] [Abstract][Full Text] [Related]
6. HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy.
Miller RL; Ponte R; Jones BR; Kinloch NN; Omondi FH; Jenabian MA; Dupuy FP; Fromentin R; Brassard P; Mehraj V; Chomont N; Poon AFY; Joy JB; Brumme ZL; Routy JP;
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189714
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.
Huang Y; Hoque MT; Jenabian MA; Vyboh K; Whyte SK; Sheehan NL; Brassard P; Bélanger M; Chomont N; Fletcher CV; Routy JP; Bendayan R
J Antimicrob Chemother; 2016 Jul; 71(7):1954-65. PubMed ID: 27076103
[TBL] [Abstract][Full Text] [Related]
8. T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment.
Cobos Jiménez V; Wit FW; Joerink M; Maurer I; Harskamp AM; Schouten J; Prins M; van Leeuwen EM; Booiman T; Deeks SG; Reiss P; Kootstra NA;
J Infect Dis; 2016 Jul; 214(2):216-25. PubMed ID: 27073222
[TBL] [Abstract][Full Text] [Related]
9. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
10. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
11. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT
Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people.
Ambada GN; Ntsama CE; Nji NN; Ngu LN; Sake CN; Lissom A; Tchouangeu FT; Tchadji J; Sosso M; Etoa FX; Nchinda GW
Immunology; 2017 Aug; 151(4):405-416. PubMed ID: 28375551
[TBL] [Abstract][Full Text] [Related]
13. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
14. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
[TBL] [Abstract][Full Text] [Related]
15. CD4
Song CB; Zhang LL; Wu X; Fu YJ; Jiang YJ; Shang H; Zhang ZN
J Transl Med; 2020 Feb; 18(1):95. PubMed ID: 32093678
[TBL] [Abstract][Full Text] [Related]
16. Partial recovery of senescence and differentiation disturbances in CD8
Eberhard JM; Ahmad F; Hong HS; Bhatnagar N; Keudel P; Schulze Zur Wiesch J; Schmidt RE; Meyer-Olson D
Clin Exp Immunol; 2016 Nov; 186(2):227-238. PubMed ID: 27377704
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP;
J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404
[TBL] [Abstract][Full Text] [Related]
18. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
Kolber MA
AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
[TBL] [Abstract][Full Text] [Related]
19. Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
Rasmussen TA; McMahon J; Chang JJ; Symons J; Roche M; Dantanarayana A; Okoye A; Hiener B; Palmer S; Lee WS; Kent SJ; Van Der Weyden C; Prince HM; Cameron PU; Lewin SR
AIDS; 2017 Aug; 31(13):1839-1845. PubMed ID: 28514279
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.
Jenabian MA; Patel M; Kema I; Vyboh K; Kanagaratham C; Radzioch D; Thébault P; Lapointe R; Gilmore N; Ancuta P; Tremblay C; Routy JP
Clin Exp Immunol; 2014 Oct; 178(1):102-11. PubMed ID: 24924152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
